Brimonidine Tartrate NDC 24208-411

NDC codes

FDA NDC Directory

Product NDC (as listed)24208-411Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24208-0411Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
24208-411-05	24208041105	1 BOTTLE, DROPPER in 1 CARTON (24208-411-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from May 28, 2003
24208-411-10	24208041110	1 BOTTLE, DROPPER in 1 CARTON (24208-411-10) / 10 mL in 1 BOTTLE, DROPPERMarketed from May 28, 2003
24208-411-15	24208041115	1 BOTTLE, DROPPER in 1 CARTON (24208-411-15) / 15 mL in 1 BOTTLE, DROPPERMarketed from May 28, 2003

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brimonidine Tartrate
Generic name (nonproprietary): brimonidine tartrate
Active ingredients: Brimonidine tartrate — 2 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Bausch & Lomb Incorporated
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076260
Marketing start: May 28, 2003
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)
Identifiers: Product ID 24208-411_1d9d2634-f10e-8fc0-e063-6394a90a1bedSPL ID 1d9d2634-f10e-8fc0-e063-6394a90a1bedSPL set ID 865f88b0-b13e-4607-a314-939f1b331e6fRxCUI 861200UNII 4S9CL2DY2H
Pharmacologic class: alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208041105 followed by a unit qualifier and the quantity

Package 24208-0411-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 19, 2024.

Indications (excerpt from the label)

Brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. The IOP lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored. Brimonidine tartrate ophthalmic solution 0.2% is an alpha adrenergic agonist indicated for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)